Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Soundthinking Signs $114M M&A Deal with Transom Capital Group, LLC
SoundThinking, Inc. has entered into a definitive agreement to be acquired by Transom Capital Group via a tender offer for $8.00 per share in cash plus a contingent value right (CVR) worth up to $3.00. The deal implies an upfront enterprise value of approximately $114 million, representing a 46% premium to the company's prior closing price, and will result in SoundThinking becoming a private company.
Cartesian Therapeutics announced positive 12-month retreatment data from its Phase 2 trial of Descartes-08 in patients with myasthenia gravis (MG). The data showed that patients who were retreated after symptom recurrence experienced deep and durable responses, with a mean MG-ADL score reduction of 6.6 points at 12 months and no new safety signals. Topline data from the Phase 3 AURORA trial is expected in the first quarter of 2027.
Invivyd announced positive topline results from its LIBERTY Phase 3 study, which demonstrated that its COVID-19 monoclonal antibody candidate, VYD2311, had safety and tolerability superior to an mRNA-based vaccine. The company plans to use data from LIBERTY and the ongoing DECLARATION pivotal study to support a Biologics License Application (BLA) submission to the FDA via the Accelerated Approval Program.
1 800 Flowers Com Divestiture to PlanetArt, LLC for $45M
1-800-FLOWERS.COM, Inc. has entered into a definitive agreement to sell its Personalization Businesses, including PersonalizationMall.com and Things Remembered, to PlanetArt, LLC for $45 million in cash. The divestiture is intended to sharpen the company's portfolio focus on its primary brands and strengthen its financial position for strategic growth initiatives. The parties also plan to enter into a commercial agreement allowing 1-800-FLOWERS.COM to continue offering select personalized products to its customers post-closing.
BeyondSpring Divestiture to Biolin Investment Limited
BeyondSpring entered into a definitive agreement to sell its majority equity interest in its Chinese subsidiary, Bulin, to Biolin Investment Limited. In exchange for the equity, the investor will fund and conduct the China portion of the global Phase 3 DUBLIN-4 trial for Plinabulin, which is expected to cover approximately 50% of the total trial enrollment.
CID Holdco Signs $65M M&A Deal with Envoy Technologies, Inc.
CID HoldCo, Inc. entered into a definitive Securities Purchase Agreement to acquire 100% of Envoy Technologies, Inc. from BladeRanger Ltd. for $65 million in stock. The consideration consists of approximately 10.8 million shares of common and Series C preferred stock valued at a reference price of $6.00 per share, including shares allocated to settle a $12.5 million convertible note.
Immix Biopharma announced positive interim results from its Phase 2 NEXICART-2 clinical trial of NXC-201 in relapsed/refractory AL Amyloidosis, showing an 89% complete response rate across 45 patients. The company noted that MRD-negativity predicts future complete responses, potentially increasing the rate to 98%, and plans a BLA submission for the therapy in mid-2027.
Alzamend Neuro presented Phase 1/2A clinical trial data for AL001, a novel organic lithium salt, at the ISMRT Conference. The study utilized 7T MRI imaging to evaluate brain pharmacokinetics, demonstrating that AL001 is designed for improved brain delivery with lower systemic exposure compared to standard inorganic lithium salts.
Stewards Signs $90M M&A Deal with Envy Development DE, LLC and Envy Recreational, LLC
Stewards, Inc. completed the acquisition of Envy Development DE, LLC and Envy Recreational, LLC, which own the real estate assets of Envy Pompano Beach, for an aggregate purchase price of $90.0 million. The consideration consisted of $44.6 million in refinanced debt, $42.8 million in common stock (14,263,025 shares), and a $2.0 million unsecured promissory note. A portion of the shares (7 million) were placed in escrow to be redeemed for cash payments of $3.0 million monthly starting in October 2026.
Value
$90M
Counterparty
Envy Development DE, LLC and Envy Recreational, LLC
Summit Therapeutics entered into a securities purchase agreement with AstraZeneca for a $2.0 billion private placement of newly designated Class A Convertible Preferred Stock. The preferred shares are priced at a common stock equivalent of $18.3561 per share and will be used to support the development of ivonescimab, including new clinical collaborations with AstraZeneca's oncology portfolio.
Value
$2B
Counterparty
AstraZeneca Holdings B.V.
“This significant investment, as well as the collaboration, is a powerful validation of the potential of ivonescimab. We are proud to welcome AstraZeneca as a strategic investor as we continue to work with purposeful urgency to make a significant difference for patients with cancer by improving outcomes.”
Robert W. Duggan, Chairman and Co-Chief Executive Officer of Summit Therapeutics
“The developments announced today with AstraZeneca open an exciting new chapter in the advancement of ivonescimab. With a growing body of evidence supporting ivonescimab’s differentiated PD-1 / VEGF bispecific approach, we look forward to further broadening the development plan of ivonescimab and initiating new clinical trials exploring the potential to combine ivonescimab with promising novel anti-cancer compounds, including ADCs, to bring together complementary approaches to tumor-cell killing, antitumor immunity, and the tumor microenvironment.”
Dr. Maky Zanganeh, President and Co-Chief Executive Officer of Summit Therapeutics
VerifyMe, Inc. provided a status update on its pending merger with Open World Ltd. by filing required pro forma financial information and audited financial statements for the target company as requested by Nasdaq. The transaction, originally announced in February 2026, involves Open World becoming a wholly owned subsidiary of VerifyMe.
Futurewave Acquisition Signs $400M M&A Deal with Olympian Group Inc.
Futurewave Acquisition Corporation (FWAC), a SPAC, has entered into a definitive merger agreement to acquire Olympian Group Inc., a Hong Kong-based provider of integrated chip and electronic component solutions. The transaction values Olympian at an agreed net value of $400 million, with Olympian shareholders receiving 40 million shares of the combined company at $10.00 per share. Upon closing, the combined entity is expected to remain listed on the Nasdaq Stock Market.
AAR CORP. has entered into a definitive agreement to acquire a 65% controlling interest in MRO Holdings for approximately $2.6 billion in cash and preferred stock. The deal creates the world's largest heavy maintenance MRO provider, adding over $1 billion in annual revenue and significantly expanding AAR's EBITDA margins. The transaction is expected to close in the third fiscal quarter ending February 2027.
Value
$2.6B
Counterparty
MRO Holdings, Inc.
“Through the acquisition of MRO Holdings, we will create the largest heavy maintenance MRO in the world, servicing a combined total of nearly 3,000 aircraft per year in our hangars. As a result of this scale, we expect to drive additional volume through our Component MRO facilities, we will have a much larger channel for new and existing OEM distribution relationships, and we will have additional avenues for data collection supporting our software business.”
John M. Holmes, Chairman, President and CEO of AAR
“The transaction structure allows us to partner with a proven team that brings decades of experience in a strategically important region. This structure also provides the financial flexibility to continue to pursue AAR’s broader strategy. This highly strategic acquisition is truly transformational for AAR and marks a significant step in our long-term growth plan.”
John M. Holmes, Chairman, President and CEO of AAR
Bayview Acquisition Corp received notice that the Nasdaq Listing and Hearing Review Council affirmed a prior decision to delist the company's securities. The delisting stems from the company's failure to complete its business combination with Oabay Inc. by the June 19, 2026 deadline. The company intends to transition the listing of its ordinary shares and rights to the OTC Pink Market.
AIxCrypto Holdings M&A Deal with Faraday Future Intelligent Electric Inc.
AIxCrypto Holdings, Inc. entered into a non-binding term sheet to acquire the robotics business (RobotCo) from its majority stockholder, Faraday Future Intelligent Electric Inc. (FFAI). The proposed transaction is being reviewed by a Special Committee of independent directors due to its related-party nature and remains subject to the negotiation of definitive agreements and a fairness opinion.
National Healthcare Properties Divestiture to unaffiliated third party for $531M
National Healthcare Properties, Inc. announced that certain termination rights have expired under a purchase and sale agreement to sell its portfolio of 40 outpatient medical facilities for approximately $531 million. The transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions.
Clearway Energy Signs $230M M&A Deal with Swan CE Seller LLC
Clearway Energy LLC's subsidiary, Swan Purchaser LLC, entered into a definitive agreement to acquire membership interests in Swan TargetCo LLC for approximately $230 million. The target company will indirectly own Swan Solar LLC, which is developing a 650-megawatt solar facility in Bates County, Missouri. The transaction is expected to close in the third quarter of 2028.
Clearway Energy Signs $230M M&A Deal with Swan CE Seller LLC
Clearway Energy, through its subsidiary Swan Purchaser LLC, has entered into a definitive agreement to acquire membership interests in Swan TargetCo LLC for approximately $230 million in cash. The target company will indirectly own Swan Solar LLC, which is developing a 650-megawatt solar facility in Bates County, Missouri. The transaction is expected to close in the third quarter of 2028, subject to customary conditions.
Viking Therapeutics closed a public equity offering of 9,035,714 shares of common stock at $35.00 per share, including the full exercise of the underwriters' overallotment option. The company raised approximately $297.0 million in net proceeds from the equity portion. Simultaneously, the company issued $258.75 million in 2.00% Convertible Senior Notes due 2032 to further strengthen its balance sheet.
Value
$316M
Counterparty
Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC
Kodiak Gas Services M&A Deal with Distributed Power Solutions, LLC
Kodiak Gas Services, Inc. filed an amendment to provide pro forma financial information regarding its previously completed acquisition of Distributed Power Solutions, LLC (DPS). The filing includes unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2026, treating the acquisition as if it had occurred on January 1, 2025.
Nexalin Technology received a notification from the Nasdaq Hearings Panel granting a conditional extension to regain compliance with listing standards. The company must demonstrate a minimum bid price of $1.00 for 20 consecutive trading sessions by September 28, 2026, and meet the $2.5 million stockholders' equity requirement by January 4, 2027.
Faraday Future Intelligent Electric Divestiture to AIxCrypto Holdings, Inc for $200M
Faraday Future Intelligent Electric Inc. entered into a non-binding term sheet to sell its robotics business to its majority-owned subsidiary, AIxCrypto Holdings, Inc., for $200 million. The consideration will be paid in AIxC common and non-voting convertible preferred stock, and the transaction is being reviewed by a Special Committee of the Board due to its related-party nature.
Viking Acquisition Corp I M&A Deal with NorthStar Earth & Space Inc.
Viking Acquisition Corp. I (VACI) announced that its previously disclosed business combination with NorthStar Earth & Space Inc. is expected to close on September 30, 2026. Following the merger, the combined company will be renamed NorthStar Earth & Space Enterprises, Inc. and will transfer its listing to the NYSE American under the ticker 'NSTR' on October 1, 2026.
Greenland Mines Ltd. entered into a securities purchase agreement with institutional investors to issue 1,320,000 shares of common stock in a direct registered offering. The company expects to receive approximately $17.2 million in net proceeds to fund its Greenland mining operations and general working capital. Additionally, the company terminated its previously established $50 million at-the-market offering program with A.G.P./Alliance Global Partners.
SilverBox Corp IV announced that its units, Class A ordinary shares, and warrants have been delisted from the New York Stock Exchange effective September 28, 2026. The securities have transitioned to the OTCID Basic Market and are now trading under the new ticker symbols SBXUF, SBXDF, and SBXWF, respectively.
McCormick & Company provided a status update on its pending acquisition of Unilever's foods business, noting that the deal's anticipated closing will cause its current auditor, Ernst & Young LLP, to lose independence. Consequently, the company has appointed KPMG LLP as its new independent registered public accounting firm effective for the fiscal year ending November 30, 2027.
Keurig Dr Pepper completed the divestiture of its indirect equity interests in Chobani and the sale of certain assets, including leasehold interests in two Pennsylvania facilities, to Chobani. The total consideration of $925 million consists of $525 million in cash and an $800 million promissory note maturing in December 2026. This transaction represents a full exit from the company's investment in Chobani alongside an asset disposal.
Isabella Bank Signs $18.3M M&A Deal with Grand River Commerce, Inc.
Isabella Bank Corporation provided a status update on its pending acquisition of Grand River Commerce, Inc., announcing the mailing of election materials to shareholders. Grand River shareholders have until October 23, 2026, to elect to receive cash (estimated at $5.71 per share) or Isabella common stock (estimated exchange ratio of 0.1413) as merger consideration.
Cambium Networks Divestiture to Airspan Communications Limited for $27.5M
Cambium Networks Corporation's subsidiary, Cambium Networks, Ltd (in administration), completed the sale of its defense business and certain fixed broadband product lines to Airspan Communications Limited for $27.5 million in cash. The deal includes a contingent earn-out of up to $7.5 million based on accounts receivable collections and involves transitional services and licensing agreements. The company does not expect to retain any net proceeds as the funds will be applied toward the subsidiary's administration and secured credit facility obligations.
Advanced Micro Devices Signs $8.2B M&A Deal with World Labs Technologies, Inc.
Advanced Micro Devices (AMD) entered into a definitive agreement to acquire World Labs Technologies, Inc. for approximately $8.2 billion. The transaction will be paid entirely in AMD common stock, with the final share count determined by a 10-day volume-weighted average price prior to closing. The acquisition represents a significant strategic investment in AI and computing technology.